Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Stuart Millheiser Discusses How the Different Causes of ALS Should Influence Treatment Plans | ||
| By: PR Newswire Association LLC. - 03 Aug 2015 | Back to overview list |
|
NEW YORK, Aug. 3, 2015 /PRNewswire-iReach/ -- Stuart Millheiser is the founder of ALS Guardian Angels, an organization that is dedicated to improving the lives ALS patients. The charity provides both financial relief and an extensive support network for those battling this debilitating disease. According to Stu Millheiser, amyotrophic lateral sclerosis attacks motor neurons that are responsible for activating voluntary muscles. These muscles allow us to walk, breathe, talk and perform crucial bodily functions without thinking. ALS causes muscle twitching and stiffening before it progresses to paralysis. Eventually, the disease steals the patient's ability to breathe. ALS is always fatal, usually taking patients' lives within two to five years of diagnosis. In 90 percent of cases, the cause of ALS remains unknown. In the other 10 percent, patients receive mutated C9orf72 genes from their parents. Despite the Ice Bucket Challenge and other efforts that have raised millions in ALS research, there still is no cure. Scientists speculate that this is partly due to a lack of understanding about how ALS progresses. However, a recent study has helped researchers identify the differences between hereditary ALS and the more prevalent form of the disease. Scientists from Mayo Clinic's Florida campus tried to identify abnormalities in the processing and levels of ribonucleic acids, or RNAs. These molecules act as the "middleman" between protein synthesis and genetic data. While various similarities exist between the two variations of ALS, the study's findings suggest additional differences between cases of C9orf72 mutation and the altered RNAs found in sporadic cases. These results indicate that different factors contribute to ALS development, and the cause should influence each patient's treatment plan. The study offers much-needed guidance in the highly pioneered world of ALS therapy. The researchers also discovered a great deal of new information about ALS and its progression. In addition to offering invaluable data for therapy research, the team's findings will aid in the development of early diagnostics and in the identification of prognostic factors. Stuart Millheiser is the founder of ALS Guardian Angels. Millheiser founded ALS Guardian Angels in 2007 to help patients that are suffering from ALS, formerly known as Lou Gehrig's disease. Millheiser has helped hundreds of people with ALS by providing everything from medical equipment to support for basic living expenses. Millheiser has been referred to as "a true angel on earth" for his charitable work. He feels a sense of accomplishment by helping those in need. After the viral spreading of the ice bucket challenge during the summer of 2014, Millheiser is hopeful that more people will continue to become aware of ALS and support this truly important cause. Media Contact: Stuart Millheiser, ALS Guardian Angels, 949-488-9894, info@alsguardianangels.com News distributed by PR Newswire iReach: https://ireach.prnewswire.com SOURCE ALS Guardian Angels 
|
||
|
|
||
 | Back to overview list | |